Anti-TL1A Antibody, Afimkibart, in Moderately-to-severely Active Ulcerative Colitis (TUSCANY-2): A Multicentre, Double-blind, Treat-through, Multi-dose, Randomised, Placebo-controlled, Phase 2b Trial

Danese, Silvio; Allegretti, Jessica R; Schreiber, Stefan; Peyrin-Biroulet, Laurent; Jairath, Vipul; D'Haens, Geert; Kierkuś, Jarosław; Leong, Rupert W; Yarur, Andres J; Vincent, Michael S; Banerjee, Anindita; Chandra, Deepa E; Peeva, Elena; Neelakantan, Srividya; Hung, Kenneth E; McBride, Jacqueline M; Bojic, Daniela; Lasch, Karen; Schiffman, Courtney; Feagan, Brian G